Phyllis Illari

In this paper, we examine what is to be said in defence of Machamer, Darden and Craver’s controversial dualism about activities and entities (MDC 2000). We explain why we believe the notion of an activity to be a novel, valuable one, and set about clearing away some initial objections that can lead to its being brushed aside unexamined. We argue that substantive debate about ontology can only be effective when desiderata for an ontology are explicitly articulated. We distinguish three such desiderata. The first is a more permissive descriptive ontology of science, the second a more reductive ontology prioritising understanding, and the third a more reductive ontology prioritising minimalism. We compare MDC’s entities-activities ontology to its closest rival, the entities-capacities ontology, and argue that the entities-activities ontology does better on all three desiderata.

This book is the first to develop explicit methods for evaluating evidence of mechanisms in the field of medicine. It explains why it can be important to make this evidence explicit, and describes how to take such evidence into account in the evidence appraisal process. In addition, it develops procedures for seeking evidence of mechanisms, for evaluating evidence of mechanisms, and for combining this evaluation with evidence of association in order to yield an overall assessment of effectiveness. Evidence-based medicine seeks to achieve improved health outcomes by making evidence explicit and by developing explicit methods for evaluating it. To date, evidence-based medicine has largely focused on evidence of association produced by clinical studies. As such, it has tended to overlook evidence of pathophysiological mechanisms and evidence of the mechanisms of action of interventions. The book offers a useful guide for all those whose work involves evaluating evidence in the health sciences, including those who need to determine the effectiveness of health interventions and those who need to ascertain the effects of environmental exposures.

Evidence-based medicine (EBM) makes use of explicit procedures for grading evidence for causal claims. Normally, these procedures categorise evidence of correlation produced by statistical trials as better evidence for a causal claim than evidence of mechanisms produced by other methods. We argue, in contrast, that evidence of mechanisms needs to be viewed as complementary to, rather than inferior to, evidence of correlation. In this paper we first set out the case for treating evidence of mechanisms alongside evidence of correlation in explicit protocols for evaluating evidence. Next we provide case studies which exemplify the ways in which evidence of mechanisms complements evidence of correlation in practice. Finally, we put forward some general considerations as to how the two sorts of evidence can be more closely integrated by EBM.

Mechanisms have become much-discussed, yet there is still no consensus on how to characterise them. In this paper, we start with something everyone is agreed on – that mechanisms explain – and investigate what constraints this imposes on our metaphysics of mechanisms. We examine two widely shared premises about how to understand mechanistic explanation: (1) that mechanistic explanation offers a welcome alternative to traditional laws-based explanation and (2) that there are two senses of mechanistic explanation that we call ‘epistemic explanation’ and ‘physical explanation’. We argue that mechanistic explanation requires that mechanisms are both real and local. We then go on to argue that real, local mechanisms require a broadly active metaphysics for mechanisms, such as a capacities metaphysics.

The Recursive Bayesian Net (RBN) formalism was originally developed for modelling nested causal relationships. In this paper we argue that the formalism can also be applied to modelling the hierarchical structure of mechanisms. The resulting network contains quantitative information about probabilities, as well as qualitative information about mechanistic structure and causal relations. Since information about probabilities, mechanisms and causal relations is vital for prediction, explanation and control respectively, an RBN can be applied to all these tasks. We show in particular how a simple two-level RBN can be used to model a mechanism in cancer science. The higher level of our model contains variables at the clinical level, while the lower level maps the structure of the cell's mechanism for apoptosis.

In this paper, we compare the mechanisms of protein synthesis and natural selection. We identify three core elements of mechanistic explanation: functional individuation, hierarchical nestedness or decomposition, and organization. These are now well understood elements of mechanistic explanation in fields such as protein synthesis, and widely accepted in the mechanisms literature. But Skipper and Millstein have argued (2005) that natural selection is neither decomposable nor organized. This would mean that much of the current mechanisms literature does not apply to the mechanism of natural selection. We take each element of mechanistic explanation in turn. Having appreciated the importance of functional individuation, we show how decomposition and organization should be better understood in these terms. We thereby show that mechanistic explanation by protein synthesis and natural selection are more closely analogous than they appear—both possess all three of these core elements of a mechanism widely recognized in the mechanisms literature.

The Recursive Bayesian Net (RBN) formalism was originally developed for modelling nested causal relationships. In this paper we argue that the formalism can also be applied to modelling the hierarchical structure of mechanisms. The resulting network contains quantitative information about probabilities, as well as qualitative information about mechanistic structure and causal relations. Since information about probabilities, mechanisms and causal relations is vital for prediction, explanation and control respectively, an RBN can be applied to all these tasks. We show in particular how a simple two-level RBN can be used tomodel a mechanism in cancer science. The higher level of our model contains variables at the clinical level, while the lower level maps the structure of the cell’s mechanism for apoptosis.

The Recursive Bayesian Net formalism was originally developed for modelling nested causal relationships. In this paper we argue that the formalism can also be applied to modelling the hierarchical structure of mechanisms. The resulting network contains quantitative information about probabilities, as well as qualitative information about mechanistic structure and causal relations. Since information about probabilities, mechanisms and causal relations is vital for prediction, explanation and control respectively, an RBN can be applied to all these tasks. We show in particular how a simple two-level RBN can be used to model a mechanism in cancer science. The higher level of our model contains variables at the clinical level, while the lower level maps the structure of the cell's mechanism for apoptosis.

In this chapter we put forward more theoretical proposals for gathering evidence of mechanisms. Specifically, the chapter covers the identification of a number of mechanism hypotheses, formulation of review questions for search, and then how to refine and present the resulting evidence. Key issues include increased precision concerning the nature of the hypothesis being examined, attention to differences between the study population (or populations) and the target population of the evidence assessors, and being alert for masking mechanisms, which are other mechanisms which may mask the action of the mechanism being assessed. An outline example concerning probiotics and dental caries is given. (Databases that may be helpful for some searches can be found online in Appendix A ).

Further considerations need to be borne in mind for evidence appraisal in areas beyond clinical medicine, such as public health. This chapter looks at how public health has treated associations and correlations. Then it examines the importance to public health of mechanisms operating at the group and individual level, concerning social interactions and support, access to socio-sanitary infrastructures, psychological factors, and so on, which have to be explored in the appraisal of public health evidence. Finally, the chapter considers the relationship between biological and social factors, and the difference between mechanisms of disease and mechanisms of prevention.

Current research in molecular epidemiology uses biomarkers to model the different disease phases from environmental exposure, to early clinical changes, to development of disease. The hope is to get a better understanding of the causal impact of a number of pollutants and chemicals on several diseases, including cancer and allergies. In a recent paper Russo and Williamson (Med Stud, 2012) address the question of what evidential elements enter the conceptualisation and modelling stages of this type of biomarkers research. Recent research in causality has examined Ned Hall’s distinction between two concepts of causality: production and dependence (Hall in Causation and counterfactuals. MIT Press, Cambridge, pp 225–276, 2004). In another recent paper, Illari (Philos Technol, p 20, 2011b) examined the relatively under-explored production approach to causality, arguing that at least one job of an account of causal production is to illuminate our inferential practices concerning causal linking. Illari argued that an informational account solves existing problems with traditional accounts. This paper follows up this previous work by investigating the nature of the causal links established in biomarkers research. We argue that traditional accounts of productive causality are unable to provide a sensible account of the nature of the causal link in biomarkers research, while an informational account is very promising.

This chapter offers a brief summary of mechanisms, as including complex-system mechanisms (a complex arrangement of entities and activities, organised in such a way as to be regularly or predictably responsible for the phenomenon to be explained) and mechanistic processes (a spatio-temporal pathway along which certain features are propagated from the starting point to the end point). The chapter emphasises that EBM+ is concerned with evidence of mechanisms, not mere just-so stories, and summarises some key roles assessing evidence of mechanisms can play, particularly with respect to assessing efficacy and external validity.

This chapter introduces the idea of EBM+, which adopts the explicit requirements of EBM, to (1) make all the key evidence explicit and (2) adopt explicit methods for evaluating that evidence. EBM+ then sets out to get us better causal knowledge by explicitly integrating evidence of mechanism alongside evidence of correlation. This chapter summarises some important benefits of including evidence of mechanism, particularly given how highly idealised study populations typically are, and introduces the need to make uses of evidence of mechanism more explicit.

This chapter introduces how to assess evidence of mechanisms, explaining a summary protocol for use of evidence of mechanisms in assessing efficacy, then external validity (developed theoretically in Part III, with tools for implementation offered in Part II). An outline of quality assessment—of a whole body of evidence, rather than individual studies—is given. The chapter finishes with a brief introduction to the ideas developed in Part III: gathering evidence of mechanisms (Chap. 5 ); evaluating evidence of mechanisms (Chap. 6 ); and using evidence of mechanisms to evaluate causal claims (Chap. 7 ).

If theoretical developments in evidence assessment are to prove useful, guidance on implementation is essential, and this chapter fills that need. A variety of tools are offered, which can be used either in isolation, or in the various combinations suggested. The starting point is an Is your policy really evidence-based? tool which should be very widely usable to give a very quick overview. Then two tools are offered for guideline developers for medical practice; these offer improved assessment of evidence of mechanism in assessing clinical trials, and, if needed, in basic science papers. For politicians, journalists, academics, and so on, a critical appraisal tool is offered alongside GRADE-style tables for mechanism assessment. A final tool is designed specifically for public health and social care.

The use of evidence in medicine is something we should continuously seek to improve. This book seeks to develop our understanding of evidence of mechanism in evaluating evidence in medicine, public health, and social care; and also offers tools to help implement improved assessment of evidence of mechanism in practice. In this way, the book offers a bridge between more theoretical and conceptual insights and worries about evidence of mechanism and practical means to fit the results into evidence assessment procedures.

The Routledge Handbook of Causality and Causal Methods adopts a pluralistic, interdisciplinary approach to causality. It formulates distinct questions and problems of causality as they arise across scientific and policy fields. Exploring, in a comparative way, how these questions and problems are addressed in different areas, the Handbook fosters dialogue and exchange. It emphasizes the role of the researchers and the normative considerations that arise in the development of methodological and empirical approaches. The Handbook includes authors from all over the world and with many different disciplinary backgrounds, and its 51 chapters appear in print here for the first time. The chapters are organized into the following seven parts: I. Causal Pluralism, from Theory to Practice II. Causal Theory and the Role of Researchers III. Features of Causal Systems IV. Causal methods, Experimentation and Observation V. Measurement and Data VI. Causality, Knowledge, and Action VII. Causal Theory across Disciplinary Borders Essential reading for scholars interested in an interdisciplinary approach to causality and causal methods, the volume is also a valuable resource for advanced undergraduates as well as for graduate students interested in delving into the rich field of causality.